Skip links

Archive

43 North Announces Semi-Finalists (Spoiler: this one’s connected to UR technologies)

43 North Announces Semi-Finalists (Spoiler: this one’s connected to UR technologies)

in

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies. SmartDialysis (Rochester, NY) is trying to create a portable hemodialysis device

A New Look for Our Website

A New Look for Our Website

in

The UR Ventures web site underwent a minor update last week. We have simplified navigation within the site, hopefully making the things you’re looking for a little easier to find. As always, we welcome your feedback. Send comments and suggestions to the e-mail link, below.

Wegman Foundation Donates $17 Million for Children’s Hospital and Institute for Data Science

Wegman Foundation Donates $17 Million for Children’s Hospital and Institute for Data Science

in

Today, University of Rochester President Joel Seligman announced two extraordinary gifts from The Wegman Family Charitable Foundation (WFCF): a $10 million lead gift to the University’s Institute for Data Science and a $7 million gift to support Golisano Children’s Hospital. Together with previous gifts to

iCardiac Technologies Partners with Norwest Venture Partners to Accelerate Growth

iCardiac Technologies Partners with Norwest Venture Partners to Accelerate Growth

in

Palo Alto, CA – March 6, 2014 — iCardiac Technologies, Inc., a leading global provider of cardiac safety assessment services, today announced a partnership transaction with Norwest Venture Partners (NVP), a global, multi-stage investment firm with $3.7 billion in capital under management. iCardiac will leverage the

SRO at UVANY Venture Forum

SRO at UVANY Venture Forum

in

More than 150 entrepreneurs and venture capitalists from throughout New York State gathered at Brighton’s ARTISANworks Tuesday evening to network and to hear some Rochester success stories. Organized by the Upstate Venture Association of New York (UVANY), the event featured an introductory presentation on “The

Dr. Nedergaard’s Sleep Research Receives Worldwide Attention

Dr. Nedergaard’s Sleep Research Receives Worldwide Attention

in

Everyone is talking about Dr. Nedergaard’s discovery. We can’t blame them. This has huge potential. But don’t take our word for it . . . . io9: http://bit.ly/1gOM5U3 Science Magazine: http://bit.ly/1hU0D8N NIH News Update: http://1.usa.gov/1kuEP5b Neuroscience News: http://bit.ly/MKUAWP NBC: http://nbcnews.to/1bXANQb BBC: http://bbc.in/1dXojTM NPR: http://n.pr/1ddsU37 NY

MiniVax, Inc. and University of Rochester Enter into Option for Antibody Treatment against Pneumocystis pneumonia

MiniVax, Inc. and University of Rochester Enter into Option for Antibody Treatment against Pneumocystis pneumonia

in

NEW ORLEANS & ROCHESTER, N.Y.–(BUSINESS WIRE)–MiniVax, Inc. (New Orleans, LA) and the University of Rochester (Rochester, NY) announce that they have entered into an exclusive option agreement with agreed licensing terms to develop a monoclonal antibody for the treatment of Pneumocystis pneumonia (PCP). The antibody